Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials?
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.17241
Abstract: Keith Gomez, Mike Laffan and Charlotte Bradbury Haemophilia Centre and Thrombosis Unit, Royal Free Hospital London NHS Foundation Trust, London, Department of Immunity and Inflammation, Centre for Haematology, Faculty of Medicine, Imperial College London, London,… read more here.
Keywords: dose duration; duration anticoagulants; prevention venous; anticoagulants prevention ... See more keywords
Cost-effectiveness of direct acting oral anticoagulants in the prevention of thromboembolic complications: limits and concerns of economic evaluations.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of cardiovascular medicine"
DOI: 10.2459/jcm.0000000000000805
Abstract: : Economic evaluations have a widespread application in many areas of clinical research and play a key role in the clinical decision-making process. However, economic analyses have been sometimes used to produce new 'evidence' that… read more here.
Keywords: economic evaluations; anticoagulants prevention; oral anticoagulants; direct acting ... See more keywords